Novavax Inc. (NVAX)
NASDAQ · Healthcare
Novavax Inc. Income Statement 2010–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenue | 1.12B | 682.2M | 983.7M | 1.98B | 1.15B | 475.6M | 18.7M | 34.3M | 31.2M | 15.4M | 36.3M | 30.7M | 20.9M | 22.1M | 14.7M | 343,000 |
| Gross Profit | 1.05B | 479.4M | 639.9M | 1.08B | 1.15B | 475.6M | — | — | — | — | — | — | — | — | — | — |
| Profitability | ||||||||||||||||
| Operating Income | 452.8M | -248.9M | -566.5M | -644.7M | -1.69B | -416.7M | -120.6M | -173.9M | -171.7M | -269.1M | -157.2M | -83.7M | -52.4M | -29.7M | -21.6M | -38.5M |
| EBITDA | 480.8M | -200.9M | -525.5M | -615.7M | -1.67B | -412.4M | -115.5M | -166.5M | -164.1M | -261.4M | -152.1M | -79.3M | -49.8M | -28.0M | -20.0M | -37.1M |
| Net Income | 440.3M | -187.5M | -545.1M | -657.9M | -1.74B | -418.3M | -132.7M | -184.7M | -183.8M | -280.0M | -156.9M | -82.9M | -52.0M | -28.5M | -19.4M | -35.7M |
| Per Share Data | ||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 173M | 152M | 101M | 78M | 74M | 58M | 24M | 19M | 323M | 271M | 270M | 239M | 209M | 148M | 117M | 111M |
Novavax Inc. Income Statement — FAQ
Novavax Inc. (NVAX) income statement over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see NVAX's income statement history?
The chart and table above show Novavax Inc.'s income statement by year and by quarter, including the growth rate.